MCTA · Company research

Charming Medical Limited Class A Ordinary Shares (MCTA): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

14records availableHealthcare

Stock News & Events data

Database-backed records only

14 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) Stock Price, News & Analysis - kalkine.caCharming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) Stock Price, News & Analysis kalkine.caView source ↗kalkine.caOct 8, 2026neutral00.6
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) Stock Price, News & Analysis - KalkineCharming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA) Stock Price, News & Analysis KalkineView source ↗KalkineSep 30, 2026neutral00.6
All News for MCTA : Charming Medical Limited - Zacks Investment ResearchAll News for MCTA : Charming Medical Limited Zacks Investment ResearchView source ↗Zacks Investment ResearchAug 15, 2026neutral00.6
MCTA Shareholders Have Opportunity to Lead Charming Medical Ltd - The National Law ReviewMCTA Shareholders Have Opportunity to Lead Charming Medical Ltd The National Law ReviewView source ↗The National Law ReviewAug 8, 2026neutral00.6
Deadline Soon: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business WireDeadline Soon: Charming Medical Limited (MCTA) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit Business WireView source ↗Business WireFeb 12, 2026neutral00.6
Charming Medical (MCTA) Stock Price, News & Analysis - MarketBeatCharming Medical (MCTA) Stock Price, News & Analysis MarketBeatView source ↗MarketBeatJan 28, 2026neutral00.6
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTA - PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTA PR NewswireView source ↗PR NewswireJan 22, 2026neutral00.6
CHARMING ALERT: Bragar Eagel & Squire, P.C. Announces that - GlobeNewswireCHARMING ALERT: Bragar Eagel & Squire, P.C. Announces that GlobeNewswireView source ↗GlobeNewswireJan 5, 2026neutral00.6
Charming Medical Limited - Class A Ordinary Shares (MCTA) Stock Price, News, Quote & History - FinancialContentCharming Medical Limited - Class A Ordinary Shares (MCTA) Stock Price, News, Quote & History FinancialContentView source ↗FinancialContentDec 23, 2025neutral00.6
Securities Fraud Investigation Into Charming Medical Limited (MCTA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - Business WireSecurities Fraud Investigation Into Charming Medical Limited (MCTA) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Business WireView source ↗Business WireDec 23, 2025neutral00.6
Charming Medical (MCTA) Stock Forecast & Analyst Ratings - MoomooCharming Medical (MCTA) Stock Forecast & Analyst Ratings MoomooView source ↗MoomooOct 28, 2025neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNOct 21, 2025neutral00.6
Charming Medical Limited (MCTA) Stock Price, News, Quote & History - Yahoo! Finance CanadaCharming Medical Limited (MCTA) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 21, 2025neutral00.6
Charming Medical Limited (MCTA) stock price, news, quote and history - Yahoo Finance SingaporeCharming Medical Limited (MCTA) stock price, news, quote and history Yahoo Finance SingaporeView source ↗Yahoo Finance SingaporeOct 20, 2025neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.